Transaction DateRecipientSharesTypePriceValue
6th January 2021Capital, Llc Armistice1,531,101Open or private purchase$5.23$8,000,002.73
6th January 2021Capital, Llc Armistice0Open or private purchase$0.00
10th December 2020Christopher Ryan Sullivan5,095Open or private purchase$2.28$11,606.41
10th December 2020James Archie Jr Harrell171Open or private purchase$2.28$389.54
10th December 2020Garry Arthur Neil3,599Open or private purchase$2.28$8,198.52
4th December 2020Capital, Llc Armistice5,400Open or private purchase$4.13$22,302.00
4th December 2020Capital, Llc Armistice0Open or private purchase$0.00
3rd December 2020Capital, Llc Armistice20,000Open or private purchase$2.44$48,800.00
3rd December 2020Capital, Llc Armistice0Open or private purchase$0.00
2nd December 2020Capital, Llc Armistice1,000Open or private purchase$4.31$4,310.00
Cerecor
Cerecor logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.


Ticker: CERC
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1534120
Employees: 64
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $45 M (0%)
Inventory, Net: $12 Th (-42%)
Assets, Current: $50 M (183%)
Property, Plant and Equipment, Net: $2 M (20%)
Assets: $69 M (91%)
Accounts Payable, Current: $3 M (23%)
Liabilities, Current: $15 M (20%)
Other Liabilities, Noncurrent: $2 M (82%)
Liabilities: $19 M (23%)
Common Stock, Value, Issued: $75 Th (68%)
Common Stock, Shares, Issued: $75 M (68%)
Retained Earnings (Accumulated Deficit): $149 M (0%)
Stockholders' Equity (Parent): $51 M (0%)
Liabilities and Equity: $69 M (91%)
Revenue: $1 M (0%)
Cost of Revenue: $78 Th (-46%)
Sales and Marketing: $653 Th (-50%)
General and Administrative Expenses: $6 M (-30%)
Operating Income/Loss: $12 M (-72%)
Other Income, net: $1 M (-74%)
Provision for income taxes: $454 Th (-9%)